The AWS Diagnostic Development Initiative will support projects that are using AWS to support research-oriented workloads across four program areas: early disease detection, diagnostics, prognosis, and public health genomics. Given the need, the emphasis initially will be on COVID-19, but we will also consider applications for other infectious diseases. We will not support administrative workloads to run routine IT operations through this program. Eligible projects can include molecular (nucleic acid, antibody, or antigen) tests, in addition to imaging diagnostics (MRI, CT scan, Ultrasound, X-Ray), connected medical devices, wearables, medical IoT, or predictive analytic tools like artificial intelligence (AI) and machine learning (ML).
We are committing $20 million over two years to accelerate research, innovation, and development to speed our collective understanding and detection of COVID-19 and other innovative solutions in four areas to mitigate current and future infectious disease outbreaks.